A framework for assessing the risk of resistance for anti-malarials in development

ABSTRACT: Resistance is a constant challenge for anti-infective drug development. Since they kill sensitive organisms, anti-infective agents are bound to exert an evolutionary pressure toward the emergence and spread of resistance mechanisms, if such resistance can arise by stochastic mutation events. New classes of medicines under development must be designed or selected to stay ahead in this vicious circle of resistance control. This involves both circumventing existing resistance mechanisms and selecting molecules which are resilient against the development and spread of resistance. Cell-based screening methods have led to a renaissance of new classes of anti-malarial medicines, offering us the potential to select and modify molecules based on their resistance potential. To that end, a standardized in vitro methodology to assess quantitatively these characteristics in Plasmodium falciparum during the early phases of the drug development process has been developed and is presented here. It allows the identification of anti-malarial compounds with overt resistance risks and the prioritization of the most robust ones. The integration of this strategy in later stages of development, registration, and deployment is also discussed.     

Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes

For many years, the development of insulin resistance has been seen as the core defect responsible for the development of Type 2 diabetes. However, despite extensive research, the initial factors responsible for insulin resistance development have not been elucidated. If insulin resistance can be overcome by enhanced insulin secretion, then hyperglycaemia will never develop. Therefore, a β-cell defect is clearly required for the development of diabetes. There is a wealth of evidence to suggest that disorders in insulin secretion can lead to the development of decreased insulin sensitivity. In this review, we describe the potential initiating defects in Type 2 diabetes, normal pulsatile insulin secretion and the effects that disordered secretion may have on both β-cell function and hepatic insulin sensitivity. We go on to examine evidence from physiological and epidemiological studies describing β-cell dysfunction in the development of insulin resistance. Finally, we describe how disordered insulin secretion may cause intracellular insulin resistance and the implications this concept has for diabetes therapy. In summary, disordered insulin secretion may contribute to development of insulin resistance and hence represent an initiating factor in the progression to Type 2 diabetes.     

Development of drug resistance and the cross resistance in Shigella to certain chemotherapeutic preparations in vitro]

A total of 700 Shigella cultures isolated in different regions of the Ukraine in 1974 and occasionally in 1971-1973 were studied. No cultures resistant to furazolidone or enteroseptol were found. Under the experimental conditions resistance to nitrofuran and especially oxycholine preparations in Shigella developed slowly when the cultures were passaged in broths with increasing concentrations of the drugs. Cross resistance in Shigella was observed with respect to (a) various nitrofuran preparations, less pronounced with respect to furacryline and (b) enteroseptol and 5-NOK. No cross resistance was noted between the above groups of the chemotherapeutics and levomycetin and tetracycline. 5-NOK inhibited the resistance development to streptomycin, while enteroseptol inhibited the development of resistance to furazolidone in Shigella. The studies showed that in the near future there will be observed no mass development of resistance to furazolidone and enteroseptol in Shigella.     

Emergence and development of resistance to antimicrobial chemicals and heat in spores of Bacillus subtilis

The emergence and development of chemical and thermal resistance in spores of Bacillus subtilis was examined. The chemicals studied were of the disinfectant type: glutaraldehyde, hypochlorite, hypochlorite-methanol and povidone-iodine. Growth and sporulation were followed by electron microscopy and resistance assigned to specific stages in relation to 45Ca and DPA accumulation. A sequential development of resistance was observed with thermal resistance appearing first at early Stage V corresponding to maturation of cortex and deposition of rudimentary spore coat material. Chemical resistance coincided with middle to late Stage V dependent on the chemical concerned. A progressive development of resistance was observed on prolonged incubation in sporulation medium and was affected by inclusion of lysozyme in the spore washing sequence.     

Emergence and development of resistance to antimicrobial chemicals and heat in spores of Bacillus subtilis

The emergence and development of chemical and thermal resistance in spores of Bacillus subtilis was examined. The chemicals studied were of the disinfectant type: glutaraldehyde, hypochlorite, hypochlorite-methanol and povidone-iodine. Growth and sporulation were followed by electron microscopy and resistance assigned to specific stages in relation to ⁴⁵Ca and DPA accumulation. A sequential development of resistance was observed with thermal resistance appearing first at early Stage V corresponding to maturation of cortex and deposition of rudimentary spore coat material. Chemical resistance coincided with middle to late Stage V dependent on the chemical concerned. A progressive development of resistance was observed on prolonged incubation in sporulation medium and was affected by inclusion of lysozyme in the spore washing sequence.     

活性污泥抗生素抗性基因研究进展

抗生素抗性在全球范围内的传播扩散严重威胁人类健康。活性污泥是污水处理系统重要的处理工艺,同时也是抗生素抗性及其发生水平基因转移的一个重要储库和热区。目前,随着研究手段和技术的不断更新,活性污泥中抗生素抗性的研究不断增加,但是仍有许多科学问题亟待解决。本文主要针对活性污泥抗生素抗性的5个主要方面进行深入讨论:(1)活性污泥中抗性基因的丰度和分布的影响因素;(2)污泥抗性基因的研究方法;(3)活性污泥抗性基因的传播与扩散;(4)污泥中抗性基因环境风险评估;(5)研究展望。本综述在活性污泥抗生素抗性研究基础上,阐述了驱动抗生素抗性扩散的基本微生物生态过程研究进展,旨在为污水处理工艺的发展和优化及抗性基因控制政策的制定提供科学基础。     

In vivo T cell depletion regulates resistance and morbidity in murine schistosomiasis

These studies assessed the roles of subpopulations of T lymphocytes in inducing and modulating resistance to schistosomiasis and thereby influencing subsequent morbidity. C57BL/6 mice were depleted in vivo of Lyt-1+, Lyt-2+, and L3T4+ cells by the daily administration of monoclonal antibodies. The development of protective immunity, induced by exposure to irradiated Schistosoma mansoni cercariae as expressed in depleted animals, was compared to that demonstrated in undepleted, normal, and congenitally athymic C57BL/6 mice. The development of morbidity was determined by spleen weight, portal pressure and reticuloendothelial system activity. The results indicated that depletion of specific subpopulations of T lymphocytes minimally affected the primary development of parasites; however, depletion strongly influenced the development of resistance to the parasite and subsequent morbidity due to infection. Depletion of T lymphocytes by anti-Lyt-1+ or anti-L3T4+ antibody decreased the development of resistance, antibody and delayed-type hypersensitivity directed against schistosome antigens. Morbidity due to disease was increased. Depletion of Lyt-2+ cells produced opposite changes with augmented resistance and reduced morbidity. Congenitally athymic mice developed minimal resistance and morbidity. Moreover, resistance was inversely related to the morbidity shown by a given animal. These studies indicate that the development of protective immunity to S. mansoni cercariae is regulated by discrete subpopulations of T lymphocytes. The feasibility of decreasing morbidity by increasing specific immunologically mediated resistance is suggested.     

棉铃虫对辛硫磷抗性的风险评估与预报

在室内用辛硫磷对采自江苏东台的棉铃虫Helicoverpa armigera连续筛选了12代,平均成活率为37.6%,抗性上升了4.9倍。据Tabashnik介绍的方法,估计了抗性现实遗传力为0.0865。并预报了棉铃虫对辛硫磷的抗性发展速率。还对抗性风险评估、影响抗性发展速率的因素及抗性治理进行了讨论。     

Overcoming kinase resistance in chronic myeloid leukemia

Imatinib is a small-molecule inhibitor of BCR-ABL tyrosine kinase activity, with proven efficacy and tolerability. Despite imatinib's activity, the development of resistance, whether BCR-ABL dependent or independent, is a concern. BCR-ABL-dependent resistance is commonly a result of mutations in the BCR-ABL gene, which can induce a structural predisposition towards the active conformation of the protein, resulting in a shift in the equilibrium of BCR-ABL from inactive, which imatinib binds, to active, which imatinib is unable to bind. BCR-ABL gene amplification may play a role in the development of imatinib resistance in patients with CML. There are a number of BCR-ABL-independent mechanisms of imatinib resistance, including the efflux protein multidrug resistance protein-1, of which imatinib is a substrate. Another mechanism may be the development of alternative pathways of disease progression, leading to less reliance on BCR-ABL; indeed, the SRC family tyrosine kinases LYN and HCK have been frequently implicated in treatment resistance and progression of CML. Clearly, imatinib resistance requires the development of other treatment options. Dasatinib, with increased binding potency (325-fold greater potency than imatinib for wild-type BCR-ABL), inhibition of both the active and inactive formation of BCR-ABL, and targeting of SRC family kinases, is the only agent approved for the treatment of patients with imatinib-resistant or -intolerant CML and Ph+ ALL. Dasatinib is highly active in all phases of these diseases, and is active in the majority of imatinib-resistant mutations, with the exception of T315I. The development of agents that effectively inhibit T315I mutations suggests that future treatment options will include combination therapy.     

昆虫乙酰胆碱酯酶基因变异抗药性机制研究

有机磷和氨基甲酸酯类杀虫剂的大量使用导致昆虫对其产生抗药性。乙酰胆碱酯酶是昆虫对这类杀虫剂产生抗性的重要的靶标酶,昆虫产生抗药性的重要原因之一,就是因为乙酰胆碱酯酶的基因表达量上升,或基因突变而导致其敏感性下降。文章简要论述昆虫乙酰胆碱酯酶基因发生变异而导致的抗药性,分析了变异对其结构和功能的影响。     

钠氢交换蛋白NHE1与肿瘤耐药

化疗药物耐药逐渐成为肿瘤治疗的主要障碍。肿瘤耐药的发生机制主要包括药物的外排增加、DNA修复增强、凋亡受抑、上皮 间质转化以及肿瘤干细胞的存在。因此，迫切需要寻找新的生物标志物，通过逆转肿瘤的耐药性，从而增加化疗药物的疗效，以提高患者的总体生存率。钠氢交换蛋白 (sodium hydrogen exchanger 1, NHE1) 在调控肿瘤细胞的增殖、凋亡和耐药中发挥重要作用，被认为是肿瘤治疗中调控耐药性的潜在靶标。本文简要介绍钠氢交换蛋白的结构和主要功能，重点阐述钠氢交换蛋白对肿瘤耐药的影响和调控机制，以及在肿瘤的发展、转移中的作用的研究进展。     

天敌昆虫抗药性研究进展

天敌昆虫抗药性研究在协调害虫化学防治和生物防治中有着重要的理论和现实意义,其研究的最终目的在于更好地推进抗性天敌在害虫综合治理(IPM)中的应用。抗药性天敌昆虫具有潜在的巨大价值。鉴于此,本文系统地综述了天敌昆虫抗药性最新研究进展,包括杀虫剂对天敌昆虫的影响、天敌昆虫抗药性现状、抗药性机理和限制天敌昆虫抗药性发展因素等。文章最后还对抗药性天敌昆虫的应用前景进行了展望。     

Influence of biocide treatment regimen on resistance development to methylchloro-/methylisothiazolone in Pseudomonas aeruginosa

Resistance development among microbial populations exposed to industrial biocides intending to control microbial levels has received increasing attention in the last few years. Usually studies dealing with resistance development are done after the process has taken place. Characterization of resistant organisms by isolation of dominant populations reveals some details, but the steps leading to resistance usually remain unclear. In this study, development of resistance to methylchloro-/methylisothiazolone (IT) biocide under laboratory conditions is described. Results with experimental setups relevant to field dosing conditions demonstrated how the pattern of biocide treatment influenced the degree of resistance development. The induction of higher resistance in the laboratory populations exposed to different dosing patterns varied. Sequential treatment of culture with a constant increase in concentrations of isothiazolone (5–10 μl l⁻¹ of commercial product) resulted in increasing resistance, exceeding ten-fold. However, additional increases of 25–50 μl l⁻¹ in each step were lethal, suggesting threshold levels of resistance in populations tested. Extrapolation of laboratory data to field conditions appeared more relevant after Pseudomonas species, highly resistant to IT, were isolated from metalworking fluids. In these fluids the biocide treatment regimen in the field was similar to the one used in the laboratory. An understanding of the factors contributing to resistance development and selection in the field is emphasized.     

Prevention of the development of melphalan resistance in vitro by selenite

Exposure of A2780 human ovarian tumor cells to a low concentration of melphalan in vitro for 7 d results in the development of melphalan resistance, which is dependent on elevated cellular levels of glutathione and glutathioneS-transferase. The inclusion of selenite (at concentrations as low as 0.2 ΜM) during the exposure to melphalan completely prevented the development of resistance. Selenite did not prevent the melphalan-induced increase in glutathione, but it did prevent the increase in the activity of glutathioneS-transferase. It also prevented the increase in the expression of the glutathioneS-transferase gene, suggesting that this may be the mechanism by which it prevents the development of melphalan resistance. The results of this in vitro study suggest that selenite may prove to be useful in preventing the development of drug resistance in vivo.     

Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells

Acquisition of platinum resistance following first line platinum/taxane therapy is commonly observed in ovarian cancer patients and prevents clinical effectiveness. There are few options to prevent platinum resistance; however, demethylating agents have been shown to resensitize patients to platinum therapy thereby demonstrating that DNA methylation is a critical contributor to the development of platinum resistance. We previously reported the Epidermal Growth Factor Receptor (EGFR) is a novel regulator of DNA methyltransferase (DNMT) activity and DNA methylation. Others have shown that EGFR activation is linked to cisplatin treatment and platinum resistance. We hypothesized that cisplatin induced activation of the EGFR mediates changes in DNA methylation associated with the development of platinum resistance. To investigate this, we evaluated EGFR signaling and DNMT activity after acute cisplatin exposure. We also developed an in vitro model of platinum resistance to examine the effects of EGFR inhibition on acquisition of cisplatin resistance. Acute cisplatin treatment activates the EGFR and downstream signaling pathways, and induces an EGFR mediated increase in DNMT activity. Cisplatin resistant cells also showed increased DNMT activity and global methylation. EGFR inhibition during repeated cisplatin treatments generated cells that were more sensitive to cisplatin and did not develop increases in DNA methylation or DNMT activity compared to controls. These findings suggest that activation of EGFR during platinum treatment contributes to the development of platinum resistance. Furthermore, EGFR inhibition may be an effective strategy at attenuating the development of platinum resistance thereby enhancing the effectiveness of chemotherapeutic treatment in ovarian cancer.     

Frequency of bacteriocin resistance development and associated fitness costs in Listeria monocytogenes

Bacteriocin-producing starter cultures have been suggested as natural food preservatives; however, development of resistance in the target organism is a major concern. We investigated the development of resistance in Listeria monocytogenes to the two major bacteriocins pediocin PA-1 and nisin A, with a focus on the variations between strains and the influence of environmental conditions. While considerable strain-specific variations in the frequency of resistance development and associated fitness costs were observed, the influence of environmental stress seemed to be bacteriocin specific. Pediocin resistance frequencies were determined for 20 strains and were in most cases ca. 10(-6). However, two strains with intermediate pediocin sensitivity had 100-fold-higher pediocin resistance frequencies. Nisin resistance frequencies (14 strains) were in the range of 10(-7) to 10(-2). Strains with intermediate nisin sensitivity were among those with the highest frequencies. Environmental stress in the form of low temperature (10 degrees C), reduced pH (5.5), or the presence of NaCl (6.5%) did not influence the frequency of pediocin resistance development; in contrast, the nisin resistance frequency was considerably reduced (<5 x 10(-8)). Pediocin resistance in all spontaneous mutants was very stable, but the stability of nisin resistance varied. Pediocin-resistant mutants had fitness costs in the form of reduction down to 44% of the maximum specific growth rate of the wild-type strain. Nisin-resistant mutants had fewer and less-pronounced growth rate reductions. The fitness costs were not increased upon applying environmental stress (5 degrees C, 6.5% NaCl, or pH 5.5), indicating that the bacteriocin-resistant mutants were not more stress sensitive than the wild-type strains. In a saveloy-type meat model at 5 degrees C, however, the growth differences seemed to be negligible. The applicational perspectives of the results are discussed.     

The effect of TAO expression on PCD-like phenomenon development and drug resistance in Trypanosoma brucei

Drug resistance in Trypanosoma brucei causes severe problems for people and domestic animals, but molecular mechanisms of the resistance are not well known. Programmed cell death (PCD) is a fundamental process in both multicellular and unicellular organisms, and it is speculated to be one of the important factors contributing to the emergence of drug resistance. We have previously reported that the expression of TAO appears to play a role in the inhibition of the PCD-like phenomenon development in T. brucei. In this study, to ascertain the correlation between the development of the PCD-like phenomenon and the expression of TAO in T. brucei, we genetically engineered T. brucei for conditional over-expression of the TAO gene. TAO over-expressing transgenic T. brucei was refractory to the development of the PCD-like phenomenon compared to the wild-type, indicating that expression of TAO might have a regulatory role on PCD development. Furthermore, the transgenic cells showed resistance to suramin and antrycide. We postulated that intracellular reactive oxygen species (ROS) may be involved in the mechanism of resistance to antrycide because augmentation of ROS in transgenic cells was lower than that in the wild-type cells following treatment with antrycide. These results suggest a possible correlation of PCD to drug resistance in T. brucei.     

Adriamycin resistance in HL60 cells in the absence of detectable P-glycoprotein

Previous studies have shown that the development of multi-drug resistance in cell lines treated with chemotherapeutic agents is closely associated with the overexpression of a 170-180 kilodalton surface membrane glycoprotein (P-glycoprotein). In the present study a monoclonal antibody against the P-glycoprotein was used to determine if this protein is overexpressed in multi-drug resistant HL60 cells. Using either indirect immunofluorescent staining or immunoblot analysis P-glycoprotein could not be detected in HL60 cells isolated for resistance to adriamycin. In contrast HL60 cells isolated for resistance to vincristine contain the P-glycoprotein and the amount of this material increases with increasing levels of resistance. These studies thus demonstrate adriamycin resistance in P-glycoprotein negative HL60 cells. Furthermore adriamycin and vincristine are found to have distinct effects in inducing overexpression of P-glycoprotein in the HL60 cell line. This information could be useful in the development of therapeutic strategies for the treatment of certain forms of cancer.     

植物病原真菌对二甲酰亚胺类杀菌剂的抗性分子机制

综述了近年来国内外植物病原真菌对二甲酰亚胺类杀菌剂抗性机制研究的主要成果,包括：二甲酰亚胺类杀菌剂（DCFs）的杀菌机制、植物病原菌对DCFs抗药性的产生现状、促分裂原活化蛋白激酶（MAPK）途径和依赖环化腺苷酸（cAMP）的蛋白激酶途径在抗药性产生中的可能作用及相关的分子生物学研究进展。     

Resistance to thermal stress in preadult Drosophila buzzatii: variation among populations and changes in relative resistance across life stages

Resistance to a short term exposure to a high temperature stress was examined in eggs, larvae and pupae of Drosophila buzzfltii from seven localities. Across development, pupae were most resistant, followed by eggs, and then first and third-instar larvae. Variation among populations for resistance to heat stress was significant in all life stages. However, there was much less variation among populations where measured as eggs and pupae than for both first and third instar larvae. Older larvae showed large changes both in viability and developmental time, while exposure of young larvae to heat stress led to a decline in viability without delayed development. Populations that had the shortest developmental time at 25^oC were relatively the most resistant to heat stress as larvae. High relative resistance at one preadult life stage was not necessarily associated with relatively high resistance at another, or with previous measurements of resistance for adults from these populations. Comparison of populations that were more similar in their pattern of change in resistance across development suggested a relationship with the climate of origin. The possibility that developmental variation in the expression of heat shock proteins may cause variation in resistance to thermal stress for different life stages is discussed.